Selected research
Market Structure
Global CBD Consumer Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global CBD Consumer Health market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for CBD Consumer Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CBD Consumer Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CBD Consumer Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for CBD Consumer Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of CBD Consumer Health include Elixinol Global Limited, ENDOCA, NuLeaf Naturals LLC, Kazmira, Charlotte's Web, Joy Organics, Lord Jones, Medical Marijuana Inc and CV Sciences Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global CBD Consumer Health market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CBD Consumer Health and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CBD Consumer Health sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the CBD Consumer Health market size, projected growth trends, production technologies, key applications, and end-use industries.
CBD Consumer Health Segment by Company
Elixinol Global Limited
ENDOCA
NuLeaf Naturals LLC
Kazmira
Charlotte's Web
Joy Organics
Lord Jones
Medical Marijuana Inc
CV Sciences Inc
Isodiol International Inc
CBD Consumer Health Segment by Type
Medical OTC Products
Nutraceuticals
CBD Consumer Health Segment by Application
Online Stores
Retail Stores
Retail Pharmacies
Others
CBD Consumer Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CBD Consumer Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CBD Consumer Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CBD Consumer Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the CBD Consumer Health market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CBD Consumer Health manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CBD Consumer Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of CBD Consumer Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Medical OTC Products
- Nutraceuticals
Applications
- Online Stores
- Retail Stores
- Retail Pharmacies
- Others
Companies covered
- Elixinol Global Limited
- ENDOCA
- NuLeaf Naturals LLC
- Kazmira
- Charlotte's Web
- Joy Organics
- Lord Jones
- Medical Marijuana Inc
- CV Sciences Inc
- Isodiol International Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global CBD Consumer Health Market Size, 2021 VS 2025 VS 2032
- 1.3 Global CBD Consumer Health Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global CBD Consumer Health Sales Estimates and Forecasts (2021-2032)
- 1.5 Global CBD Consumer Health Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global CBD Consumer Health Market Dynamics
- 2.1 CBD Consumer Health Industry Trends
- 2.2 CBD Consumer Health Industry Drivers
- 2.3 CBD Consumer Health Industry Opportunities and Challenges
- 2.4 CBD Consumer Health Industry Restraints
3 CBD Consumer Health Market by Manufacturers
- 3.1 Global CBD Consumer Health Revenue by Manufacturers (2021-2026)
- 3.2 Global CBD Consumer Health Sales by Manufacturers (2021-2026)
- 3.3 Global CBD Consumer Health Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global CBD Consumer Health Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global CBD Consumer Health Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global CBD Consumer Health Manufacturers, Product Type & Application
- 3.7 Global CBD Consumer Health Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global CBD Consumer Health Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 CBD Consumer Health Players Market Share by Revenue in 2025
- 3.8.3 2025 CBD Consumer Health Tier 1, Tier 2, and Tier 3
4 CBD Consumer Health Market by Type
- 4.1 CBD Consumer Health Type Introduction
- 4.1.1 Medical OTC Products
- 4.1.2 Nutraceuticals
- 4.2 Global CBD Consumer Health Sales by Type
- 4.2.1 Global CBD Consumer Health Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global CBD Consumer Health Sales by Type (2021-2032)
- 4.2.3 Global CBD Consumer Health Sales Market Share by Type (2021-2032)
- 4.3 Global CBD Consumer Health Revenue by Type
- 4.3.1 Global CBD Consumer Health Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global CBD Consumer Health Revenue by Type (2021-2032)
- 4.3.3 Global CBD Consumer Health Revenue Market Share by Type (2021-2032)
5 CBD Consumer Health Market by Application
- 5.1 CBD Consumer Health Application Introduction
- 5.1.1 Online Stores
- 5.1.2 Retail Stores
- 5.1.3 Retail Pharmacies
- 5.1.4 Others
- 5.2 Global CBD Consumer Health Sales by Application
- 5.2.1 Global CBD Consumer Health Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global CBD Consumer Health Sales by Application (2021-2032)
- 5.2.3 Global CBD Consumer Health Sales Market Share by Application (2021-2032)
- 5.3 Global CBD Consumer Health Revenue by Application
- 5.3.1 Global CBD Consumer Health Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global CBD Consumer Health Revenue by Application (2021-2032)
- 5.3.3 Global CBD Consumer Health Revenue Market Share by Application (2021-2032)
6 Global CBD Consumer Health Sales by Region
- 6.1 Global CBD Consumer Health Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global CBD Consumer Health Sales by Region (2021-2032)
- 6.2.1 Global CBD Consumer Health Sales by Region (2021-2026)
- 6.2.2 Global CBD Consumer Health Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America CBD Consumer Health Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America CBD Consumer Health Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe CBD Consumer Health Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe CBD Consumer Health Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific CBD Consumer Health Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific CBD Consumer Health Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa CBD Consumer Health Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa CBD Consumer Health Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global CBD Consumer Health Revenue by Region
- 7.1 Global CBD Consumer Health Revenue by Region
- 7.1.1 Global CBD Consumer Health Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global CBD Consumer Health Revenue by Region (2021-2026)
- 7.1.3 Global CBD Consumer Health Revenue by Region (2027-2032)
- 7.1.4 Global CBD Consumer Health Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America CBD Consumer Health Revenue (2021-2032)
- 7.2.2 North America CBD Consumer Health Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe CBD Consumer Health Revenue (2021-2032)
- 7.3.2 Europe CBD Consumer Health Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific CBD Consumer Health Revenue (2021-2032)
- 7.4.2 Asia-Pacific CBD Consumer Health Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa CBD Consumer Health Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa CBD Consumer Health Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Elixinol Global Limited
- 8.1.1 Elixinol Global Limited Company Information
- 8.1.2 Elixinol Global Limited Business Overview
- 8.1.3 Elixinol Global Limited CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Elixinol Global Limited CBD Consumer Health Product Portfolio
- 8.1.5 Elixinol Global Limited Recent Developments
- 8.2 ENDOCA
- 8.2.1 ENDOCA Company Information
- 8.2.2 ENDOCA Business Overview
- 8.2.3 ENDOCA CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ENDOCA CBD Consumer Health Product Portfolio
- 8.2.5 ENDOCA Recent Developments
- 8.3 NuLeaf Naturals LLC
- 8.3.1 NuLeaf Naturals LLC Company Information
- 8.3.2 NuLeaf Naturals LLC Business Overview
- 8.3.3 NuLeaf Naturals LLC CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 NuLeaf Naturals LLC CBD Consumer Health Product Portfolio
- 8.3.5 NuLeaf Naturals LLC Recent Developments
- 8.4 Kazmira
- 8.4.1 Kazmira Company Information
- 8.4.2 Kazmira Business Overview
- 8.4.3 Kazmira CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Kazmira CBD Consumer Health Product Portfolio
- 8.4.5 Kazmira Recent Developments
- 8.5 Charlotte's Web
- 8.5.1 Charlotte's Web Company Information
- 8.5.2 Charlotte's Web Business Overview
- 8.5.3 Charlotte's Web CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Charlotte's Web CBD Consumer Health Product Portfolio
- 8.5.5 Charlotte's Web Recent Developments
- 8.6 Joy Organics
- 8.6.1 Joy Organics Company Information
- 8.6.2 Joy Organics Business Overview
- 8.6.3 Joy Organics CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Joy Organics CBD Consumer Health Product Portfolio
- 8.6.5 Joy Organics Recent Developments
- 8.7 Lord Jones
- 8.7.1 Lord Jones Company Information
- 8.7.2 Lord Jones Business Overview
- 8.7.3 Lord Jones CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lord Jones CBD Consumer Health Product Portfolio
- 8.7.5 Lord Jones Recent Developments
- 8.8 Medical Marijuana Inc
- 8.8.1 Medical Marijuana Inc Company Information
- 8.8.2 Medical Marijuana Inc Business Overview
- 8.8.3 Medical Marijuana Inc CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Medical Marijuana Inc CBD Consumer Health Product Portfolio
- 8.8.5 Medical Marijuana Inc Recent Developments
- 8.9 CV Sciences Inc
- 8.9.1 CV Sciences Inc Company Information
- 8.9.2 CV Sciences Inc Business Overview
- 8.9.3 CV Sciences Inc CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 CV Sciences Inc CBD Consumer Health Product Portfolio
- 8.9.5 CV Sciences Inc Recent Developments
- 8.10 Isodiol International Inc
- 8.10.1 Isodiol International Inc Company Information
- 8.10.2 Isodiol International Inc Business Overview
- 8.10.3 Isodiol International Inc CBD Consumer Health Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Isodiol International Inc CBD Consumer Health Product Portfolio
- 8.10.5 Isodiol International Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 CBD Consumer Health Value Chain Analysis
- 9.1.1 CBD Consumer Health Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 CBD Consumer Health Production Mode & Process
- 9.2 CBD Consumer Health Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 CBD Consumer Health Distributors
- 9.2.3 CBD Consumer Health Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst